MARKET NEWS

Mateon Therapeutics & Windlas Biotech Launch India's First Combined Lung Therapy & AI Telemedicine Solution
Halberd Collaborates With GreenBioAZ for the Development of Its Patent Pending Radio Frequency Technology 
Leveraging Medical Laboratory Data for Patient Recruitment
Intra-Cellular Therapies Applies for FDA Approval of Bipolar Depression Treatment 
Celsion Corporation Receives FDA Fast Track Designation for GEN-1 in Advanced Ovarian Cancer
Catalent Announces Commercial Supply Agreement With Aurinia Pharmaceuticals 
AMRI Joins Network of Approved Manufacturers of Lipid Excipients for Pfizer-BioNTech COVID-19 Vaccine

  FEATURED EDITORIAL

  COMPANY PROFILE

ARL Bio Pharma is a contract laboratory that provides analytical and microbiological testing to pharmaceutical companies and research scientists. Our laboratory is headquartered in Oklahoma City, Oklahoma, and serves over 3,000 clients nationwide. Since 1998, ARL has supported the industry-wide commitment to deliver high-quality therapeutic drug products by providing guidance and test services for all phases of the product lifecycle following USP, FDA, and ICH guidelines. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Vaccinex Announces Signing of Two Multi-Project Deals With Leading Pharmaceutical Companies

Vaccinex Announces Signing of Two Multi-Project Deals With Leading Pharmaceutical Companies

Vaccinex, Inc. recently announced the signing of multi-project deals with two undisclosed prominent pharmaceutical companies…..

Stevanato Group Launches Artificial Intelligence Platform 

Stevanato Group Launches Artificial Intelligence Platform 

Stevanato Group has recently launched an Artificial Intelligence platform, based on Deep Learning (DL) models, that leverages the benefits of….

SIRION Biotech & Sanofi Join Forces to Develop Gene Therapies for Multiple Life-Threatening Disorders

SIRION Biotech & Sanofi Join Forces to Develop Gene Therapies for Multiple Life-Threatening Disorders

SIRION Biotech GmbH recently announced it signed a license and collaboration agreement with Sanofi to develop improved tissue-selective adeno-associated virus (AAV) vectors to realize….

Catalent to Acquire Delphi Genetics & Launch US Plasmid Manufacturing Site to Establish Global pDNA Development & Manufacturing Capabilities

Catalent to Acquire Delphi Genetics & Launch US Plasmid Manufacturing Site to Establish Global pDNA Development & Manufacturing Capabilities

Catalent and Delphi Genetics recently announced they have entered into a final and definitive agreement whereby Catalent will acquire 100% of the shares of Delphi Genetics. Catalent is also….

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

March 10 – Particle Design Technology
March 17 – Formulation Development